Dr. Jacob James Ruzevick, MD

Dr. Ruzevick practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Ruzevick's NPI, 1467721142, was assigned on December 23, 2011. Dr. Ruzevick graduated from Johns Hopkins University School of Medicine in 2014. Dr. Ruzevick holds Washington license MD61265065.

Dr. Ruzevick's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Ruzevick's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Ruzevick is also affiliated with Harborview Medical Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Ruzevick to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ruzevick practices, 4 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Ruzevick's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Dr. Ruzevick's licenses on file in 6 states: Washington, Montana, Alaska, Idaho, Oregon and California.

Dmand AI lists craniotomy among the conditions Dr. Ruzevick treats.

CMS data shows 209 Medicare services from Dr. Ruzevick across 7 procedure codes in 2024, for 111 Medicare patients. Medicare paid $13,474 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Ruzevick in 2024. The largest group is 65 to 74, with 50 patients. 66% of them have high blood pressure, and 65% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ruzevick's median patient age at 54, with 59% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ruzevick for performance year 2024, reported through an alternative payment model (APM). Dr. Ruzevick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ruzevick as offering telehealth.

Dmand AI links 43 papers to Dr. Ruzevick, published from 2011 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Brain Neoplasms, Glioblastoma and Endoscopy. Dr. Ruzevick has published most often in Oper Neurosurg (Hagerstown). Dr. Ruzevick's most frequent co-authors are Michael Lim, MD, Manuel Ferreira, MD, PhD and Gabriel Zada, MD.

CMS Open Payments shows 4 general payments to Dr. Ruzevick from 3 drug and device companies in 2025. Consulting fees make up the largest share, 90% of the total. Bioventus LLC paid the most, $1,125.

Dr. Ruzevick graduated from Johns Hopkins University School of Medicine in 2014.

Dr. Ruzevick is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.